High-rolling investors have positioned themselves bullish on Hims & Hers Health HIMS, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in HIMS often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 18 options trades for Hims & Hers Health. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 44% bearish. Among all the options we identified, there was one put, amounting to $25,740, and 17 calls, totaling $812,171.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $30.0 for Hims & Hers Health over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Hims & Hers Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims & Hers Health's whale trades within a strike price range from $10.0 to $30.0 in the last 30 days.
Hims & Hers Health Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | SWEEP | BULLISH | 08/16/24 | $7.5 | $7.4 | $7.5 | $19.00 | $96.0K | 12.9K | 2.0K |
| HIMS | CALL | SWEEP | BEARISH | 08/16/24 | $7.7 | $7.6 | $7.61 | $19.00 | $76.1K | 12.9K | 1.2K |
| HIMS | CALL | SWEEP | BEARISH | 08/16/24 | $7.7 | $7.6 | $7.6 | $19.00 | $76.0K | 12.9K | 1.9K |
| HIMS | CALL | SWEEP | BEARISH | 08/16/24 | $7.7 | $7.6 | $7.6 | $19.00 | $76.0K | 12.9K | 1.4K |
| HIMS | CALL | SWEEP | BULLISH | 08/16/24 | $7.5 | $7.4 | $7.5 | $19.00 | $62.2K | 12.9K | 2.4K |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Hims & Hers Health Standing Right Now?
- Currently trading with a volume of 3,833,949, the HIMS's price is up by 4.66%, now at $25.27.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 48 days.
What Analysts Are Saying About Hims & Hers Health
In the last month, 4 experts released ratings on this stock with an average target price of $23.0.
- An analyst from B of A Securities persists with their Buy rating on Hims & Hers Health, maintaining a target price of $22.
- An analyst from Canaccord Genuity has decided to maintain their Buy rating on Hims & Hers Health, which currently sits at a price target of $24.
- An analyst from Citigroup has revised its rating downward to Neutral, adjusting the price target to $20.
- Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Hims & Hers Health, targeting a price of $26.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims & Hers Health options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
